Lupus & antiphospholipid syndrome

Prevalence, clinical features, and possible associated factors of mesenteric vasculitis occurrence in patients with systemic lupus erythematosus: An age-, year-at systemic lupus erythematosus (SLE) diagnosis, and disease duration-controlled study

LupusPublished Matched case-control study

Authors' conclusion

LMV is a rare manifestation in SLE. Active disease, particularly in the renal and hematologic systems, was common prior to LMV onset.

Study context

Population
Thai SLE patients in a lupus cohortlupus cohort
Participants
1,538 patients
Comparison
SLE patients with lupus mesenteric vasculitis (LMV) vs matched SLE controls without LMV
  • LMVn = 31
Outcome
Prevalence of LMV
Methodological detailsmatched by age, year at SLE diagnosis and disease duration, cases:controls = 1:2
  • Matched by age, year at SLE diagnosis and disease duration
  • Cases:controls = 1:2

Main finding

As reported in the abstract

LMV

2.2%

34

Observational data: associations, not effects.

Further findings

Clinical features of LMV episodes

Nausea, vomiting and diarrhea
61.5%-69.2%
Abdominal pain
All of the patients
Diffuse abdominal pain
64.1%
Signs of peritoneal irritation
12.8%-15.4%
Small bowel and colon were common sites involved
All episodes responded well to corticosteroids and immunosuppressive drugs

Factors at LMV onset vs controls

LMV patients had more active renal, mucocutaneous and hematologic disease
Higher degree of proteinuria and SLE disease activity (mSLEDAI-2K score) in LMV
LMV patients received less prednisolone and fewer immunosuppressive drugs, but a higher daily prednisolone dose

Factors 3 months prior to LMV onset vs controls

LMV group more anemic and had higher proteinuria
LMV patients received fewer immunosuppressive drugs, but a higher daily prednisolone dose

Original publication

Prevalence, clinical features, and possible associated factors of mesenteric vasculitis occurrence in patients with systemic lupus erythematosus: An age-, year-at SLE diagnosis, and disease duration-controlled study. Lupus. Published 23 May 2025. doi:10.1177/09612033251344154

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.